- FDA approves new drug that may help stop and even reverse a rare, fatal condition that doctors call a ‘ticking time bomb’ CNN
- FDA approves Merck’s drug for rare, deadly lung condition CNBC
- FDA Approves Merck’s WINREVAIR™ (sotatercept-csrk), a First-in-Class Treatment for Adults with Pulmonary Arterial Hypertension (PAH, WHO* Group 1) Merck
- FDA Approves Sotatercept, First-in-Class Treatment for Adults With PAH AJMC.com Managed Markets Network
- Merck’s $11.5 Billion Bet on Its Next Big Drug Finally Arrives The Wall Street Journal
Tag Archives: FDA
FDA says applesauce pouches recalled for lead also contained chromium – The Hill
- FDA says applesauce pouches recalled for lead also contained chromium The Hill
- Lead-tainted applesauce pouches also contained another possible toxic substance: FDA 6abc Philadelphia
- The applesauce pouches that gave kids lead poisoning had a ‘high level’ of another toxic chemical, FDA says Fortune
- Disturbing discovery leads to recall of popular kids’ snack food: ‘The scariest thing that ever happened to me’ Yahoo Life
- FDA finds high levels of chromium in applesauce traced to lead poisoning outbreak Food Safety News
Bristol Myers and 2seventy bio say FDA delayed CAR-T therapy decision – Endpoints News
- Bristol Myers and 2seventy bio say FDA delayed CAR-T therapy decision Endpoints News
- Bristol Myers Squibb (NYSE:BMY) Falls after FDA Delays Action on Cancer Therapy – TipRanks.com TipRanks
- Bristol Myers Squibb and 2seventy bio Provide Update on U.S. FDA Review of sBLA for Abecma (idecabtagene vicleucel) in Earlier Lines of Therapy for Triple-Class Exposed Relapsed or Refractory Multiple Myeloma Bristol-Myers Squibb
- Why Is Pharma Giant Bristol-Myers Squibb (BMY) Stock Trading Lower Today? – 2seventy bio (NASDAQ:TSVT), B Benzinga
- View Full Coverage on Google News
After more reports of illnesses from recalled applesauce pouches, FDA is screening cinnamon shipments for lead – CNN
- After more reports of illnesses from recalled applesauce pouches, FDA is screening cinnamon shipments for lead CNN
- ‘A nightmare’: NC toddler’s lead exposure triggers nationwide recall of puree fruit pouches WLOS
- At least one case of lead poisoning in Onondaga County blamed on recalled applesauce WSYR
- OHA: At least six Oregon children have had high blood lead levels after eating WanaBana applesauce pouches KTVZ
- Why is there lead in some applesauce? FDA now screening cinnamon imports, as authorities brace for reports to climb CBS News
- View Full Coverage on Google News
AstraZeneca’s first-in-class FDA approval for Truqap marred by surprise restriction – FiercePharma
- AstraZeneca’s first-in-class FDA approval for Truqap marred by surprise restriction FiercePharma
- AstraZeneca’s AKT Inhibitor Wins FDA Approval for Combo Breast Cancer Treatment BioSpace
- TRUQAP™ (capivasertib) plus fulvestrant approved in the US for patients with advanced HR-positive breast cancer Business Wire
- FDA Approves Capivasertib Plus Fulvestrant in Advanced HR+/HER2– Breast Cancer With PIK3CA, AKT1, or PTEN Alterations OncLive
- FDA Approves Capivasertib Plus Fulvestrant in Advanced HR+, HER2– Breast Cancer Cancer Network
- View Full Coverage on Google News
FDA approves Junshi, Coherus’ PD-1 toripalimab for nasopharyngeal carcinoma – Endpoints News
- FDA approves Junshi, Coherus’ PD-1 toripalimab for nasopharyngeal carcinoma Endpoints News
- Coherus rejects ‘heavily discounted’ pricing on Loqtorzi, the first China-made PD-1 drug to win FDA nod FiercePharma
- FDA Approves Loqtorz Regimens for Advanced Nasopharyngeal Carcinoma Curetoday.com
- Coherus and Junshi Biosciences Announce FDA Approval of LOQTORZI™ (toripalimab-tpzi) in All Lines of Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Yahoo Finance
- Peninsula drug maker Coherus wins FDA cancer drug approval, extends one lease, exits other space – San Francisco Business Times The Business Journals
- View Full Coverage on Google News
The FDA is warning parents to test their children after lead is found in WanaBana fruit puree pouches – CNN
- The FDA is warning parents to test their children after lead is found in WanaBana fruit puree pouches CNN
- Lead present in WanaBana fruit puree pouches, FDA, state health leaders say WRAL News
- Elevated lead levels in NC children trigger recall, warning for certain WanaBana fruit puree pouches: Officials CBS17.com
- NCDHHS, FDA urging caution after lead found in WanaBana Brand Apple Cinnamon Puree WTVD-TV
- Elevated lead levels in NC children trigger recall, warning for certain WanaBana fruit puree pouches WGHP FOX8 Greensboro
- View Full Coverage on Google News
FDA approves Eli Lilly ulcerative colitis treatment Omvoh – STAT – STAT
- FDA approves Eli Lilly ulcerative colitis treatment Omvoh – STAT STAT
- Lilly’s bowel disease drug gets US FDA nod for treatment in adults Reuters
- FDA Approves Lilly’s Omvoh™ (mirikizumab-mrkz), A First-in-Class Treatment for Adults with Moderately to Severely Active Ulcerative Colitis | Eli Lilly and Company Investors | Eli Lilly and Company
- FDA Approves Lilly’s Omvoh™ (mirikizumab-mrkz), A First-in-Class Treatment for Adults with Moderately to Severely Active Ulcerative Colitis PR Newswire
- FDA Approves Lilly’s Omvoh™ (mirikizumab-mrkz), A First-in-Class Treatment for Adults with Moderately to Severely Active Ulcerative Colitis Yahoo Finance
- View Full Coverage on Google News
FDA Approves Lilly’s Omvoh™ (mirikizumab-mrkz), A First-in-Class Treatment for Adults with Moderately to Severely Active Ulcerative Colitis | Eli Lilly and Company – Investors | Eli Lilly and Company
- FDA Approves Lilly’s Omvoh™ (mirikizumab-mrkz), A First-in-Class Treatment for Adults with Moderately to Severely Active Ulcerative Colitis | Eli Lilly and Company Investors | Eli Lilly and Company
- Lilly’s bowel disease drug gets US FDA nod for treatment in adults Reuters
- FDA approves Eli Lilly ulcerative colitis treatment Omvoh – STAT STAT
- FDA Approves Lilly’s Omvoh™ (mirikizumab-mrkz), A First-in-Class Treatment for Adults with Moderately to Severely Active Ulcerative Colitis PR Newswire
- FDA Approves Lilly’s Omvoh™ (mirikizumab-mrkz), A First-in-Class Treatment for Adults with Moderately to Severely Active Ulcerative Colitis Yahoo Finance
- View Full Coverage on Google News
BAT expresses disappointment at FDA Marketing Denial Order for Vuse Alto Menthol and Mixed Berry and will immediately seek a stay of enforcement – British American Tobacco
- BAT expresses disappointment at FDA Marketing Denial Order for Vuse Alto Menthol and Mixed Berry and will immediately seek a stay of enforcement British American Tobacco
- FDA Bans Sales of Vuse Menthol E-Cigarettes The Wall Street Journal
- FDA issues ban on RJ Reynolds menthol-flavoured vapes in US Financial Times
- FDA Denies Marketing of Six Flavored Vuse Alto E-Cigarette Products Following Determination They Do Not Meet Public Health Standard PR Newswire
- UPDATE 2-US FDA blocks some flavors of British American Tobacco’s key vape brand Vuse Yahoo Finance
- View Full Coverage on Google News